CLAY THORP

Profile

First Name

: CLAY

Middle Name

:

Last Name

: THORP

Related Companies
Titles
Company Name
Related People
DIRECTOR
PHASEBIO PHARMACEUTICALS INC
JAMES BARRETT, ASHUTOSH CHILKOTI, GUY FISH, MICHAEL GUTCH, NANCY HUTSON, ROBERT INGRAM, JUSTIN KLEIN, THOMAS K LAUNDON, CAROLINE LOEWY, JONATHAN MOW, BIBHASH MUKHOPADHYAY, CHRISTOPHER PRIOR, DOUGLAS REED, TYRELL RIVERS, CRAIG ROSEN, JOHN SHARP, WILL SHEN, JOEL SUSSMAN, LINDA TUFTS, ASISH K XAVIER, ASISH K. XAVIER
DIRECTOR
CANCERGUIDE DIAGNOSTICS, INC.
WILLIAM HAAS, DAVID KING, GARHENG KONG, MYLA LAI-GOLDMAN, JUDD STAPLES
DIRECTOR
PATHFINDER THERAPEUTICS, INC.
NAJI ABUMRAD, MARC BUNTAINE, JAMES CLOAR, JOE COOK III, JOSEPH COOK, III, JOHNNY DRAKE, BOB GALLOWAY, CURTIS "SKIP" GOODE, RICHARD MOLLOY, BOB MORFF, ROBERT MORFF, BOB MORTT, CHRISTOPHER RAND, JAMES D STEFANSIC, JIM STEFANSIC
DIRECTOR
CLEARSIDE BIOMEDICAL, INC.
GERALD D. CAGLE, JERRY CAGLE, GERALD D. CAGLE, PH.D., RICHARD CROARKIN, CHARLES DEIGNAN, CHARLES A. DEIGNAN, CHARLIE DEIGNAN, JEFFREY L. EDWARDS, WILLIAM HUMPHRIES, WILLIAM D. HUMPHRIES, GEORGE LASEZKAY, GLENN NORONHA, MARK PRAUSNITZ, CHRISTY SHAFFER, CHRISTY L. SHAFFER, CHRISTY L. SHAFFER, PH.D., CLAY B. THORP, DANIEL WHITE, DANIEL H. WHITE, DEREK YOON, EVGENY ZAYTSEV
DIRECTOR
G-ZERO THERAPEUTICS, INC.
CLAUDIA A. BLACK, FREDERIC N. ESHELMAN, MICHAEL GUTCH, PETER KOLCHINSKY, RON LAUFER, THOMAS K LAUNDON, GREGORY MOSSINGHOFF, GLENN MUIR, SETH RUDNICK, SETH A. RUDNICK, CHRISTY SHAFFER, NORMAN SHARPLESS, JAY STAUN, JAY STRUM, TIMOTHY SULLIVAN, MARK A. VELLECA, CAROL WEBB, KWOK-KIN WONG
DIRECTOR
GENECENTRIC DIAGNOSTICS, INC.
PEROU V. CHARLES, DON HARDISON, DAVID NEIL HAYES, MYLA LAI-GOLDMAN, MYLA V. LAI-GOLDMAN, ARNOLD LEVINE, ARNOLD V. LEVINE, ELLEN LUBMAN, ELLEN V. LUBMAN, MICHAEL MILBURN, MICHAEL V. MILBURN, CHARLES PEROU, PRASANTH REDDY, CLAY V. THORP
DIRECTOR
G1 THERAPEUTICS, INC.
CLAUDIA A. BLACK, FREDERIC N. ESHELMAN, MICHAEL GUTCH, PETER KOLCHINSKY, RON LAUFER, THOMAS K LAUNDON, GREGORY MOSSINGHOFF, GLENN MUIR, SETH RUDNICK, SETH A. RUDNICK, CHRISTY SHAFFER, NORMAN SHARPLESS, JAY STAUN, JAY STRUM, TIMOTHY SULLIVAN, MARK A. VELLECA, CAROL WEBB, KWOK-KIN WONG
DIRECTOR
LYSOSOMAL THERAPEUTICS, INC.
CORNELIS BEEN, BRUCE BOOTH, BRUCE L. BOOTH, ROBERT CARPENTER, BERNARD DAVITIAN, DANIEL GEFFKEN, STEVEN HALL, STEVEN E. HALL, DIMITRI KRAINC, CAROLE NEUCHTERLEIN, CAROLE NUECHTERLEIN, HENRI TERMEER, PETER WIRTH
DIRECTOR
ORIG3N, INC.
ELONA BAUM, KATE BLANCHARD, DYLAN DAI, GEORGE HARA, DOUG JAMISON, TOM MAC MAHON, JONATHAN MELTZER, BYRON SMITH, ROBIN SMITH, ROBIN Y. SMITH, MEGANN VAUGHN, JUSTIN XIANG
DIRECTOR
STRIDEBIO, INC.
MAVIS ABJANDJE-MCKENNA, MAVIS AGBANDJE-MCKENNA, ARAVIND ASOKAN, MIKE DIAL, SHAAN GANDHI, KAREN HONG, ROBERT HUGHES, MICHAEL MARTIN, MARITZA MCINTYRE, WILLIAM MONTEITH, STEWART PARKER, PATRICK RITSCHEL, SAPAN SHAH, RICHARD SMITH, ERICA WHITTAKER
DIRECTOR
GENECENTRIC THERAPEUTICS, INC.
PEROU V. CHARLES, DON HARDISON, DAVID NEIL HAYES, MYLA LAI-GOLDMAN, MYLA V. LAI-GOLDMAN, ARNOLD LEVINE, ARNOLD V. LEVINE, ELLEN LUBMAN, ELLEN V. LUBMAN, MICHAEL MILBURN, MICHAEL V. MILBURN, CHARLES PEROU, PRASANTH REDDY, CLAY V. THORP
DIRECTOR
VIGIL NEUROSCIENCE, INC.
CHERYL BLANCHARD, CHERYL BLANCHARD, PH. D., BRUCE BOOTH, SUZANNE BRUHN, SHAAN GANDHI, GERHARD KOENIG, IVANA MAGOVCEVIC-LIEBISCH, SPYROS PAPAPETROPOULOS, EVAN THACKABERRY, MARY THISTLE, CHRISTOPHER VERNI, STEFAN VITOROVIC, JENNIFER ZIOLKOWSKI
DIRECTOR
PIPR THERAPEUTICS, INC.
HEATHER MADSEN, BRIDGET ANN MARTELL, DONNIE MCGRATH, ST. JOHN DONNIE MCGRATH, MARIAN NAKADA, JAMES H. ROSEN, CHRISTY SHAFFER, MONCEF SLAOUI, E. JONATHAN SODERSTROM, JONATHAN SODERSTROM, HOLDEN THORP, WILLIAM WIESLER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-11-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-10-31 
2025-06-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-06-04 
2022-09-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-09-08 
2021-08-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-13 
2021-06-15
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-18 
2021-03-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-11 
2021-01-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-12-29 
2020-09-09
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-12 
2019-11-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-10-25 
2018-09-10
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-08-27 
2018-06-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-12 
2017-01-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-01-17 
2017-01-18
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-01-30 
2017-01-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-12-22 
2016-10-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-10-03 
2015-12-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-11-25 
2015-12-08
D
Link
OTHER TECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-11-23 
2015-07-21
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-26 
2015-03-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-26 
2015-02-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-05 
2015-02-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-04 
2015-02-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-01-30 
2014-09-15
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-08-29 
2014-07-11
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-19 
2014-05-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2014-04-28 
2013-10-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-10-08 
2013-08-23
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-04-03 
2013-07-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-19 
2013-06-21
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-07 
2013-04-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-04-03 
2013-02-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-01-31 
2012-06-18
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-12-22 
2012-05-10
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2012-05-04 
2012-02-16
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-01-03 
2012-01-09
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-01-03 
2010-12-06
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-12-22 
2010-05-27
D
Link
OTHER HEALTH CARE 
 
$1 - $1,000,000 
Equity 
2010-05-25 
2010-05-27
D/A
Link
OTHER HEALTH CARE 
 
$1 - $1,000,000 
Equity 
2010-05-25 
2010-03-25
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-01-20 
2010-01-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-01-20 
2010-01-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-12-22 
2009-11-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2009-11-03